...500-MS LC Ion Trap is the instrument of choice for... reliability and productivity are essential.,...demanding LC/MS/MS applications. The system sensit...58;ect the ion trap technologys inherent advantage...
Benchtop Ductless Exhaust Fume Hood from Terra Universal, Inc.
Distillation Hood from Terra Universal, Inc.
Telomerase Gel-based assay Assay Kit, TRAPeze from CHEMICON
Biology Products:(Date:11/4/2009).... 20 Aware, Inc. (Nasdaq...ogy and biometrics software, today reported financ... 30, 2009. ,, Michael Tzannes, Aware,s Chairm...ay, we announced an agreement to sell our DSL and ...less semiconductor company being spun out of Infin...
(Date:11/4/2009)...PRNewswire/ -- Global Rainmakers, Inc., an intelle...D laboratory, today announced that the company has...vely commercialize its suite of technologies desig...ferings. ,, During the past four years, the com...lop and deploy a series of core--but expandable--t...
(Date:11/3/2009)...4, 2009 -- The world,s greatest wines are the res...man input, and something called the "terroir" -- a...d climate. , Experts will discuss terroir with...nesday, Nov. 4 in Pittsburgh. "Terroir: Winegrape...rts at the 2009 Annual Meetings of the American So...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Great wines come from great soils 2Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 1Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 1Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 3Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 4Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 5Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 1Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 2Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 3Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 4Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 5(Date:11/6/2009)...Newswire/ -- Calbiotech, Inc. announced today that...esearch (SBIR) Phase I contract by the U.S. Army M...of the agreement, Calbiotech will develop analyte ...ue virus. ,, Dengue virus is a mosquito-born...tary forces deployed to tropical areas of the worl...
(Date:11/5/2009)...wire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) t... quarter ended September 30, 2009. GenVec reported...the three months ended September 30, 2009 compared...n the comparable quarter of 2008. For the nine mon...s $14.1 million ($0.15 per share), compared to a n...
(Date:11/5/2009)...mber 5, 2009 at 4:30 p.m. Eastern Time , BOTH.../ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" o...naudited financial results for the third quarter a...ed the Company,s highlights for the third quarter ...reflect the operations of OncoGenex Technologies I...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: S...e receptor-based technologies to discover novel fl...dient supply industries, today provided a corporat...ird quarter ended September 30, 2009. Revenues we...pared to $4.0 million for the third quarter of 200...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14